Last reviewed · How we verify
Ketorolac Injection 60 mg
At a glance
| Generic name | Ketorolac Injection 60 mg |
|---|---|
| Also known as | Toradol, ketorolac tromethamine, ketorolac |
| Sponsor | William Beaumont Army Medical Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Optimizing Pain Treatment in Children On Mechanical Ventilation (PHASE3)
- Ketorolac Applied by Continuous IV Infusion for Treatment of Moderately Severe Postoperative Pain Following Bunionectomy (PHASE3)
- Intramuscular Ketorolac at Two Single-Dose Regimens (PHASE4)
- Post-Op Pain Control for Prophylactic Intramedullary Nailing. (PHASE3)
- Efficacy of Intraoperative Periarticular Injections in Hip Fracture Hemiarthroplasty (NA)
- A Prospective Study on the Comparison of Postoperative Pain According to the Use of Cocktail Therapy in Laminoplasty (PHASE4)
- Erector Spinae Plane Block Versus Paravertebral Block During Non-intubated Thoracoscopic Lung Resections. (NA)
- Effectiveness of Premedication on the Success Rate of Inferior Alveolar Nerve Block (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ketorolac Injection 60 mg CI brief — competitive landscape report
- Ketorolac Injection 60 mg updates RSS · CI watch RSS
- William Beaumont Army Medical Center portfolio CI